ABCL$12.280.82%0.10
After Hours: 12.12-0.16 -1.30%
Abcellera Biologics Inc (ABCL)
Date: 2026-11-04 16:00O: 12.33H: 12.54L: 11.53C: 12.28Vol: 2.669M
Abcellera Biologics Inc stock is traded at $12.28, with a volume of 2,669,051. It is up +0.82% in the last 24 hours and down -10.63% over the past month. AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Previous Close:
$12.18
Open:
$12.33
24h Volume:
2,669,051
Relative Volume:
0.85
Market Cap:
$3.98B
Revenue:
$79.21M
Net Income/Loss:
-$143.96M
P/E Ratio:
-
EPS:
-$0.4796
Net Cash Flow:
-$189.60M
1W Performance:
-9.97%
1M Performance:
-10.63%
6M Performance:
+167.54%
1Y Performance:
+152.16%
1-Day Range:
$11.53$12.54
1-Week Range:
$11.05$13.86
52-Week Range:
$2.75$15.02
Abcellera Biologics Inc Stock (ABCL) Company Profile
Name
Abcellera Biologics IncSector
HealthcareIndustry
BiotechnologyPhone
(604) 559-9005Address
150 W 4TH AVENUE, VANCOUVER, CanadaMarket Cap
Revenue
Net Income
Cash Flow
EPS
